Citation of paper, Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Carla Rognoni3528243.2
Lucia Sacchi31131,5472.1
Enea Parimbelli2271811.4
Carlo Napolitano223526,4696.8
Janneke Pc Grutters2972,3383.1
Andrea Mazzanti2724,5709.5
Monia Marchetti21204,1145.5
Surakit Nathisuwan1497922.2
Job Harenberg1326482.6
Lorenzo Giovanni Mantovani11866,0984.5
Fernando Lanas16813,81824.4
Nicky J Welton125013,9627.6
Jose A Lopez-Lopez1622,3047
Julian P T Higgins1364149,53442.2
Fausto Pinto136722,76911
Sakis Themistoclakis11017,6639
Unchalee Permsuwan1322962.3
Chulaporn Limwattananon18351.6
George A Scangas1427746
Graeme J Hankey1891148,84622.4
Gérard de Pouvourville1521,0181.8
Gert Jan van der Wilt11956,5203.3
Vanessa Roldan11876,5935
Chris Salisbury124510,7004.9
Onanong Waleekhachonloet110441.3
Mark G Shrime11268,29111.7
Brooke M Su1131301.9
Björn Stollenwerk1192.3
Jelena Savović16529,97764
Nai Fang Chi1626861.8
Sofia Dias11216,4387
Thomas S Higgins1393756.3
Carme Pinyol11152.5
William Hollingworth11684,0603.9
Ashton E Lehmann1252382.4
Reecha Sofat1322,29710.9
W Ken Redekop1561,3222.3
Pietro GIUSTi1873,2624.4
Arthur W Wu1434814.2
Jonathan A C Sterne134378,34028.6
Harindra C Wijeysundera12726,0894.2
Aroon D Hingorani135045,44014.4
Robis Group1664,7009.5
Fd Richard Hobbs137443,21015
Carlos Zaror1575392
Francesco Paneni11063,7255.9
Annachiara Bellin1261